Related Experiment Video
Updated: Oct 22, 2025

Screening for Amyloid Aggregation by Semi-Denaturing Detergent-Agarose Gel Electrophoresis
Published on: July 16, 2008
Membrane composition and lipid to protein ratio modulate amyloid kinetics of yeast prion protein
Arnab Bandyopadhyay1, Achinta Sannigrahi1, Krishnananda Chattopadhyay1
1Structural Biology & Bio-Informatics Division, CSIR-Indian Institute of Chemical Biology 4, Raja S. C. Mullick Road Kolkata 700032 India krish@iicb.res.in sannigrahiachinta@gmail.com.
Abstract:
Understanding of prion aggregation in a membrane environment may help to ameliorate neurodegenerative complications caused by the amyloid forms of prions. Here, we investigated the membrane binding-induced aggregation of yeast prion protein Sup35. Using the combination of fluorescence correlation spectroscopy (FCS) at single molecule resolution and other biophysical studies, we establish that lipid composition and lipid/protein ratio are key modulators of the aggregation kinetics of Sup35. In the presence of a zwitterionic membrane (DMPC), Sup35 exhibited novel biphasic aggregation kinetics at lipid/protein ratios ranging between 20 : 1 and 70 : 1 (termed here as the optimum lipid concentration, OLC). In ratios below (low lipid concentration, LLC) and above (ELC, excess lipid concentration) that range, the aggregation was found to be monophasic. In contrast, in the presence of negatively charged membranes, we did not observe any bi-phasic aggregation kinetics in the entire range of protein to lipid ratios. Our results provide a mechanistic description of the role that membrane concentration/composition-modulated aggregation may play in neurodegenerative diseases.
Insights
Yeast prion protein Sup35 aggregation is modulated by lipid concentration and membrane charge. Optimal lipid concentrations on zwitterionic membranes induced biphasic aggregation, unlike monophasic kinetics observed at other concentrations or on charged membranes.
Area of Science:
- Biophysics
- Neurodegenerative Diseases
- Prion Biology
Background:
- Prion aggregation in membranes is linked to neurodegenerative diseases.
- Understanding these mechanisms is crucial for therapeutic development.
Purpose of the Study:
- Investigate how membrane environment influences the aggregation of yeast prion protein Sup35.
- Determine the role of lipid composition and lipid/protein ratio in prion aggregation kinetics.
Main Methods:
- Utilized single-molecule resolution fluorescence correlation spectroscopy (FCS).
- Employed complementary biophysical techniques.
- Examined aggregation kinetics across various lipid compositions and protein-to-lipid ratios.
Main Results:
- Lipid composition and lipid/protein ratio significantly modulate Sup35 aggregation kinetics.
- Zwitterionic membranes (DMPC) showed biphasic aggregation at optimal lipid concentrations (OLC), but monophasic at low (LLC) and excess (ELC) concentrations.
- Negatively charged membranes did not exhibit biphasic aggregation across any tested ratio.
Conclusions:
- Membrane properties critically control prion protein aggregation pathways.
- Findings offer mechanistic insights into how membrane-modulated aggregation contributes to neurodegenerative diseases.
- Identified specific lipid concentration ranges influencing aggregation dynamics.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Biosynthesis of Lipids
Asymmetric Lipid Bilayer
Membrane Fluidity
Mosaic nature of the membrane
The mosaic characteristic of the membrane helps the plasma membrane remain fluid. The integral proteins and lipids exist as separate but loosely-attached molecules in the membrane. The membrane is...

